IP Library Granted Patent US 9,255,291
Granted Patent B2
US 9,255,291 · App. 13/102,797 · Granted Feb 9, 2016

Oligonucleotide ligation methods for improving data quality and throughput using massively parallel sequencing

Inventors: Masoud M. Toloue (Austin, TX); Marianna Goldrick (Austin, TX)
Assignee: BIOO SCIENTIFIC CORPORATION
C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,255,291
App. No.
13/102,797
Granted
Feb 9, 2016
Kind
B2
Abstract

Described herein is a buffer concentration for highly efficient ligation of two oligonucleotides. The embodiments herein have led to the development of an optimized ligation step used in the sample preparation for sequencing reactions. Further, embodiments herein describe a high-throughput method for sequencing using barcodes or the purpose of multiplexing several samples simultaneously and novel methods for making targeted DNA libraries for re-sequencing on massively parallel next-generation sequencing platforms and for alternatives to gel-purification for recovering the desired templates from small RNA libraries for next generation sequencing.

Claims (11)

1. A method for preparing nucleic acid molecules for sequencing comprising:

ligating a first oligonucleotide to the 3′ end of a nucleic acid molecule to form a first ligation product, wherein the first oligonucleotide comprises a sequence complementary to a reverse transcription primer;

annealing a first reverse transcription primer to the first oligonucleotide to reduce adapter dimer formation;

ligating a second oligonucleotide to the 5′ end of the first ligation product to form a second ligation product;

annealing a second reverse transcription primer to the first oligonucleotide, the second ligation product, or both;

reverse transcribing the second ligation product to create cDNA; and

amplifying the cDNA to create a population of nucleic acid molecules for sequencing.

2. The method of claim 1 , wherein:

the annealing of the first reverse transcription primer to the first oligonucleotide occurs after the ligating of the first oligonucleotide to the 3′ end of the nucleic acid molecule and before the ligating of the second oligonucleotide to the 5′ end of the first ligation product;

the annealing of the second reverse transcription primer occurs after the ligating of the second oligonucleotide to the 5′ end of the first ligation product; and

wherein the first reverse transcription primer and the second reverse transcription primer are the same or different.

Assignments (2)
MERGER Recorded Jan 19, 2026
From: BIOO SCIENTIFIC CORPORATION
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 073506/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2011
From: TOLOUE, MASOUD M.; GOLDRICK, MARIANNA
To: BIOO SCIENTIFIC CORPORATION
Reel/Frame 027066/0208 →
Continuity (2)
Provisional Application 61332104 · May 6, 2010
Related Publication 20120028814A1 · Feb 2, 2012